The number of jobs in Indiana’s life sciences sector grew by about 1 percent last year, to 56,323, and averages wages climbed 3 percent, to $97,607.
The figures were released Tuesday in a new study by BioCrossroads, an Indianapolis-based group that promotes and invests in the state's life sciences sector, and the Indiana Business Research Center at the Indiana University Kelley School of Business.
The sector’s economic impact, which measures company revenues, exports, capital expenditures and several other factors, edged up about 1 percent, to $79 billion.
Indiana’s life sciences payroll totaled $5.5 billion, up from $5.3 billion in 2017.
According to the annual report, the number of life science companies in the state increased to 1,751, from 1,689 last year.
The Food and Drug Administration approved 85 new products for Indiana life sciences companies last year, up from 80 in 2017.
Indiana is the global headquarters for such industry powerhouses as drugmaker Eli Lilly and Co., device maker Cook Medical, insurer Anthem Inc. and orthopedic maker Zimmer Biomet.
In addition, Indiana is the North American headquarters of Roche Diagnostics; and other life sciences companies have major operations here, including DowDuPont, Covance, Beckman Coulter, DuPuy Orthopaedics, Express Scripts and Medtronics.
BioCrossroads and the IBRI define the life sciences industry as a combination of pharmaceutical, medical device and equipment, agricultural biosciences, testing and medical laboratories, and biologistics.